|
Back to Home » November 2018 News » RXi Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights |
RXi Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights |
November 15, 2018
MARLBOROUGH, Mass., Nov. 14, 2018 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (sd-rxRNA®) therapeutic platform, reports its financial...
Source URL: https://www.prnewswire.com:443/news-releases/rxi-pharmaceuticals-reports-third-quarter-2018-financial-results-and-recent-corporate-highlights-300749899.html
|
|
|
|
